科学家发现,通过将癌症细胞中的蛋白质作为目标,可增强CAR T细胞治疗的化合物。 Scientists discover compound that could boost CAR T cell therapy by targeting a protein in cancer cells.

希望之城的科学家发现,一种叫做YTHDF2的蛋白质帮助癌症细胞避免CAR T细胞治疗,这是一种治疗血癌的治疗。 Scientists at City of Hope have found that a protein called YTHDF2 helps cancer cells avoid CAR T cell therapy, a treatment for blood cancers. 他们发现了一个新的化合物,CCI-38,目标是YTHDF2,减少癌症增长,有可能提高CAR T细胞疗法的效力。 They discovered a new compound, CCI-38, which targets YTHDF2 and reduces cancer growth, potentially enhancing CAR T cell therapy's effectiveness. 接下来的步骤包括改善CCI-38的安全性,并进行临床试验,发展更个性化的癌症治疗。 The next steps include improving CCI-38's safety and conducting clinical trials to develop more personalized cancer treatments.